Fidelity International’s Regenxbio RGNX Stock Holding History

Fidelity International’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-150,879	Closed	-$2.98M	–	514
2017 Q2	$2.98M	Sell	150,879 -151,319	-50%	-$2.93M	0.01%	428
2017 Q1	$5.83M	Hold	302,198	–	–	0.02%	395
2016 Q4	$5.61M	Sell	302,198 -75,000	-20%	-$1.43M	0.02%	384
2016 Q3	$5.29M	Hold	377,198	–	–	0.02%	388
2016 Q2	$3.02M	Buy	377,198 +127,050	+51%	+$1.41M	0.01%	421
2016 Q1	$2.7M	Buy	+250,148	New	+$3.2M	0.01%	414

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International's RGNX Position: Q3 2017 in Review

Fidelity International sold out of Regenxbio (RGNX) in Q3 2017, closing a stake of 150,879 shares — an estimated $2.98M sold.

Fidelity International first reported a position in RGNX in Q1 2016 and held it in 6 quarters. The position peaked at $5.83M in Q1 2017. 89 funds tracked by Wall St. Rank hold RGNX as of Q3 2017.

Fidelity International reported no remaining Regenxbio position as of Q3 2017 after selling out during the quarter.
Fidelity International sold 150,879 Regenxbio shares in Q3 2017, an estimated $2.98M.
Fidelity International first reported a position in Regenxbio in Q1 2016 and held it in 6 quarters.
Fidelity International's Regenxbio position peaked at $5.83M in Q1 2017.
89 funds tracked by Wall St. Rank held Regenxbio as of Q3 2017.

Based on Fidelity International's 13F filing for Q3 2017, filed 13 Nov 2017.